An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis

Patients with autoimmune hepatitis (AIH) almost inevitably require lifelong immunosuppressive treatment. There is genuine concern about the efficacy and tolerability of the current standard combination therapy of prednisolone and azathioprine. Mycophenolate mofetil (MMF) has emerged as an alternative option. The aim of this study was to compare MMF to azathioprine as induction therapy.

Source: Journal of Hepatology - December 13, 2023 Category: Gastroenterology Authors: Rom ée JALM. Snijders, Anna EC. Stoelinga, Tom JG. Gevers, Simon Pape, Maaike Biewenga, Maarten E. Tushuizen, Robert C. Verdonk, Hendrik JM. de Jonge, Jan Maarten Vrolijk, Sjoerd F. Bakker, Thomas Vanwolleghem, Ynto S. de Boer, Martine AMC. Baven Pronk, Tags: Research Article Source Type: research